Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares saw unusually-strong trading volume on Tuesday . 103,237 shares traded hands during mid-day trading, an increase of 88% from the previous session’s volume of 55,026 shares.The stock last traded at $3.6030 and had previously closed at $3.8150.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Raia Drogasil presently has a consensus rating of “Hold”.
Get Our Latest Stock Analysis on Raia Drogasil
Raia Drogasil Stock Up 1.1%
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Recommended Stories
- Five stocks we like better than Raia Drogasil
- Tesla’s Delivery Surprise Was Big—Earnings Need to Be Bigger
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
